Market revenue in 2024 | USD 8.7 million |
Market revenue in 2030 | USD 13.2 million |
Growth rate | 7.3% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Epilepsy |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 68.97% in 2024. Horizon Databook has segmented the Russia deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Russia deep brain stimulation devices market is anticipated to exhibit moderate growth rate of 7.0 % over the forecast period due to increasing incidence of mental disorders and rapidly aging population. In addition, growing research initiatives and increasing investments for the development of novel procedures involving deep brain stimulation devices are expected to contribute to the market growth in the near future.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account